An illustration of a person with their hand on another person's shoulder as if lending support, viewed from behind.
Background Gradient

You in Urology

It’s okay to ask

‘You in Urology’ is intended for people living with urological conditions (including bladder cancer, prostate cancer and overactive bladder) and their caregivers. The information provided by Astellas is for informational purposes only and is not meant to replace the advice of a healthcare professional.

 

This website was initiated and funded by Astellas Pharma Europe. All patient and healthcare organisations involved in the development of the platform received a fee for their time.

Have you been diagnosed with bladder cancer, prostate cancer or an overactive bladder, and do you…

  • Pee when you don’t mean to?
  • Avoid doing things you enjoy or social situations, because you are worried about urine leakage (sometimes called bladder leakage)?
  • Find that your urological condition is affecting your sex life, dating or relationships?
  • Find it hard to talk about your experiences?
  • Find it difficult to ask for help or information about your condition?

Then you’re not alone.

Urological conditions are health problems affecting the parts of men and women’s bodies involved in making and passing urine, or the male reproductive organs. Millions of people around the world live with urological conditions such as prostate cancer, bladder cancer and overactive bladder.1,2 Urology is the area of medicine focused on those conditions.3

 

The causes of these conditions are different, but some of the ways they impact people’s daily lives are similar. This can include uncontrollable loss of pee causing you to wet yourself (urinary incontinence). People may also experience sex and relationship challenges, impacts on family and caregivers, feeling embarrassed and effects on mental health, including the emotional impact.

Urology care should be about supporting you.

While living with a urological condition can have a big impact on your life, you don’t need to go through it alone. There is support to help you tackle this impact. It’s okay to ask!

On this website you can find:

  • Information about the ways overactive bladder, prostate cancer and bladder cancer can impact daily life
  • Tips on how to manage the day-to-day impacts of your condition 
  • Guidance on talking to your healthcare team to get the support you need
  • Links to organisations that can provide further support. 

Explore information and resources

An illustration of someone using a laptop computer, deep in thought.

Understanding urinary continence

Information about urinary incontinence and different options to manage it.

An illustration of two people in conversation, smiling.

Urological conditions, intimacy and relationships

Information about how urological conditions can affect sex, intimacy and relationships, and what can be done to help.

The ‘You in Urology’ pan-urology panel talk about why this website was created.

Developed with the patient and
healthcare community

You in Urology was developed by Astellas in partnership with a pan-urology panel of patient organisations and healthcare organisations. Working with this panel of experts will help ensure that all content is useful to and appropriate for people living with overactive bladder, prostate cancer or bladder cancer.

Logos for the European Association of Urology Patient Office, Europa Uomo, Fight Bladder Cancer, Associazione Palinuro, the World Bladder Cancer Patient Coalition and the World Federation of Incontinence and Pelvic Problems.

Astellas is not affiliated with and does not endorse any specific patient organisation or healthcare organisation.

Meet our expert panel

Patient organisations and the EAU Patient Office provide many resources across a range of topics to support people with urological conditions.

 

Please note: The following links will take you to websites which are not owned or controlled by Astellas. Astellas is not responsible for the information or services on these sites.

A portrait image of Alex Filicevas, Executive Director, World Bladder Cancer Patient Coalition.

Alex Filicevas

Executive Director, World Bladder Cancer Patient Coalition (WBCPC)

Alex Filicevas is the Executive Director of the World Bladder Cancer Patient Coalition (WBCPC) since its establishment in 2019. He leads efforts to build an international community of bladder cancer patient advocates. Alex has extensive experience in international coalitions, EU affairs at Europe's largest cancer patient federation and has worked as a consultant supporting various organisations in healthcare policy and advocacy.

A portrait image of André Deschamps, former Chairman, Europa Uomo.

André Deschamps

Former Chairman Europa Uomo

At age 51, André was diagnosed with prostate cancer and had a radical prostatectomy. Since his own experience, he became more interested in how people with cancer are treated and their quality of life after treatment. André has worked with prostate cancer organisations since 2011, and now serves as a member of the Scientific Committee at Europa Uomo.

A portrait image of Eamonn Rogers, Chair, European Association of Urology Patient Office.

Eamonn Rogers

Chair, European Association of Urology (EAU) Patient Office

Prof. Eamonn Rogers is an experienced and award-winning urologist and clinical advisor with a career spanning over 30 years. At the EAU Patient Office, he leads a team of urologists, specialist nurses and uropathologists from around Europe. This team aims to empower those living with urological conditions and elevate the level of urological care in Europe.

A portrait image of Laura Magenta, Assistant to the President, Associazione PaLiNUro.

Laura Magenta

Assistant to the President, Associazione PaLiNUro

Laura Magenta has been a bladder cancer patient since 2016, when she had a radical cystectomy. Since february 2019 she has been Assistant to the President of the PaLiNUro Association, the only Italian organisation born to inform and support patients with bladder cancer and raise awareness about it. The experience of the disease generated her choice to dedicate herself to bladder cancer patient advocacy.

A portrait image of Mary Lynne Van Polgeest-Pomfret, President, World Federation of Incontinence and Pelvic Problems.

Mary Lynne Van Poelgeest-Pomfret

President, World Federation of Incontinence and Pelvic Problems (WFIPP)

Mary Lynne Van Poelgeest-Pomfret is a dedicated international patient advocate. She became president of WFIPP in 2011. She is a member of several patient advocacy organisations, including the International Alliance of Patient Organisations (IAPO) and the European Patients Forum (EPF). She is also Co-Chair of the European Health Coalition and as such has extensive knowledge of European health affairs. She has organised numerous workshops and given presentations at major international scientific and patient advocacy events. She is also a patient with two (rare) autoimmune diseases including a rare bladder condition. 

A portrait image of Susan Richardson, Patient Advocate, Fight Bladder Cancer.

Susan Richardson

Patient Advocate, Fight Bladder Cancer (FBC)

Susan was diagnosed with stage 3 high-grade advanced bladder cancer, in November 2017. She is a mental health counsellor and patient advocate. She also enjoys family life and travel.

 

After opting for life-changing radical cystectomy surgery, Susan connected with Fight Bladder Cancer. Her mission is to continue raising awareness of bladder cancer worldwide through advocacy and patient groups.

  1. Global Cancer Observatory. Estimated number of prevalent cases, Both sexes, in 2022. All cancers. Available from: https://gco.iarc.fr/en. Last accessed: April 2026
  2. Zhang, L., Cai, N., Mo, L., Tian, X., Liu, H., & Yu, B. (2025). Global Prevalence of Overactive Bladder: A Systematic Review and Meta-analysis. Int Urogynecol J. https://doi.org/10.1007/s00192-024-06029-2
  3. Urology Care Foundation. What is Urology? Available from: https://www.urologyhealth.org/urology-a-z/what-is-urology. Last accessed: April 2026

MAT-GB-NON-2025-00402 May 2026